GOLDMAN SACHS GROUP INC - OSIRIS THERAPEUTICS INC NEW ownership

OSIRIS THERAPEUTICS INC NEW's ticker is OSIR and the CUSIP is 68827R108. A total of 92 filers reported holding OSIRIS THERAPEUTICS INC NEW in Q3 2015. The put-call ratio across all filers is 13.41 and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of OSIRIS THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2019$5,172,000
+3092.6%
272,227
+2172.2%
0.00%
Q4 2018$162,000
-3.6%
11,981
-64.7%
0.00%
Q3 2016$168,000
-34.6%
33,927
-32.7%
0.00%
Q2 2016$257,000
-18.7%
50,421
-8.9%
0.00%
Q1 2016$316,000
-35.2%
55,334
+17.8%
0.00%
Q4 2015$488,000
-47.2%
46,971
-6.1%
0.00%
Q3 2015$924,000
+453.3%
50,033
+276.9%
0.00%
Q3 2014$167,000
-25.8%
13,276
-5.0%
0.00%
Q4 2013$225,000
+5.6%
13,975
+9.4%
0.00%
Q3 2013$213,000
+26.8%
12,775
-16.3%
0.00%
Q2 2012$168,000
+48.7%
15,271
-30.9%
0.00%
Q1 2012$113,00022,0970.00%
Other shareholders
OSIRIS THERAPEUTICS INC NEW shareholders Q3 2015
NameSharesValueWeighting ↓
Consonance Capital Management LP 2,035,709$37,600,0005.29%
GREAT POINT PARTNERS LLC 75,000$1,385,0000.55%
Hood River Capital Management LLC 204,653$3,780,0000.52%
Timpani Capital Management LLC 69,640$1,286,0000.52%
RATIONAL ADVISORS LLC 64,000$1,182,0000.48%
PIPER SANDLER & CO. 22,000$406,0000.43%
PRINCETON CAPITAL MANAGEMENT INC 34,825$643,0000.39%
TFS CAPITAL LLC 101,070$1,867,0000.18%
FALCON POINT CAPITAL, LLC 26,557$491,0000.18%
EAM Investors, LLC 56,694$1,047,0000.17%
View complete list of OSIRIS THERAPEUTICS INC NEW shareholders